Imaging the binding of MECP2 to DNA
Genes & Development · 2023
DOI: 10.1101/gad.351285.123 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Genes & Development, 2023. Verfasst von Anne E West. Beteiligte Einrichtung: Department of Neurobiology, Duke University School of Medicine, Durham, North Carolina 27710, USA west@neuro.duke.edu. Hauptthemen laut MEDLINE: Rett Syndrome. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Mutations in the methyl-DNA binding domain of MECP2 cause Rett syndrome; however, distinct mutations are associated with different severity of the disease. Live-cell imaging and single-molecule tracking are sensitive methods to quantify the DNA binding affinity and diffusion dynamics of nuclear proteins. In this issue of Genes & Development , Zhou and colleagues (pp. 883–900) used these imaging methods to quantitatively describe the partial loss of DNA binding resulting from a novel pathological MECP2 mutation with intermediate disease severity. These data demonstrate how single-molecule tracking can advance understanding of the molecular mechanisms connecting MECP2 mutations with Rett syndrome pathophysiology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurobiology, Duke University School of Medicine, Durham, North Carolina 27710, USA west@neuro.duke.edu.
Zitieren
APA
West, A. E. (2023). Imaging the binding of MECP2 to DNA. Genes & Development. https://doi.org/10.1101/gad.351285.123
Vancouver
West AE. Imaging the binding of MECP2 to DNA. Genes & Development. 2023. doi:10.1101/gad.351285.123
BibTeX
@article{West2023,
author = {West, Anne E},
title = {Imaging the binding of MECP2 to DNA},
journal = {Genes & Development},
year = {2023},
doi = {10.1101/gad.351285.123}
}
EUVIMED